However, the ongoing lawsuit by OFA, filed on February 24, 2025, challenges the FDA's removal of Semaglutide from the shortage list, alleging procedural violations under the Administrative Procedure Act (GLP-1 Drugs: FDA Removes Semaglutide)
The milligram dose is the same, but the volume you draw differs dramatically
Specifications & Documentation Product Name: Reta Quantity: 10 mg Form: Lyophilized powder Grade: Research use only Storage: Protect from heat, light, and moisture Documentation: Certificate of Analysis / MSDS available Research Disclaimer Research-grade peptides, third-party lab tested
Most experts, however, are doubtful that semaglutide really increases the risk
This produces a conservative estimate of the PTEs independent contribution to total exclusivity-protected revenue